297 related articles for article (PubMed ID: 29356312)
21. Monoacylglycerol Lipase Inhibition Protects From Liver Injury in Mouse Models of Sclerosing Cholangitis.
Tardelli M; Bruschi FV; Fuchs CD; Claudel T; Auer N; Kunczer V; Baumgartner M; A H O Ronda O; Verkade HJ; Stojakovic T; Scharnagl H; Habib A; Zimmermann R; Lotersztajn S; Trauner M
Hepatology; 2020 May; 71(5):1750-1765. PubMed ID: 31505038
[TBL] [Abstract][Full Text] [Related]
22. Conditional loss of geranylgeranyl diphosphate synthase alleviates acute obstructive cholestatic liver injury by regulating hepatic bile acid metabolism.
Jia WJ; Tang QL; Jiang S; Sun SQ; Xue B; Qiu YD; Li CJ; Mao L
FEBS J; 2020 Aug; 287(15):3328-3345. PubMed ID: 31905247
[TBL] [Abstract][Full Text] [Related]
23. Protective Effects of Peroxiredoxin 4 (PRDX4) on Cholestatic Liver Injury.
Zhang J; Guo X; Hamada T; Yokoyama S; Nakamura Y; Zheng J; Kurose N; Ishigaki Y; Uramoto H; Tanimoto A; Yamada S
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149550
[TBL] [Abstract][Full Text] [Related]
24. Cholestatic liver injury increases circulating TNF-alpha and IL-6 and mortality after Escherichia coli endotoxemia.
Lechner AJ; Velasquez A; Knudsen KR; Johanns CA; Tracy TF; Matuschak GM
Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1550-8. PubMed ID: 9603137
[TBL] [Abstract][Full Text] [Related]
25. Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis.
Liu Y; Binz J; Numerick MJ; Dennis S; Luo G; Desai B; MacKenzie KI; Mansfield TA; Kliewer SA; Goodwin B; Jones SA
J Clin Invest; 2003 Dec; 112(11):1678-87. PubMed ID: 14623915
[TBL] [Abstract][Full Text] [Related]
26. Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice.
Fickert P; Fuchsbichler A; Wagner M; Zollner G; Kaser A; Tilg H; Krause R; Lammert F; Langner C; Zatloukal K; Marschall HU; Denk H; Trauner M
Gastroenterology; 2004 Jul; 127(1):261-74. PubMed ID: 15236191
[TBL] [Abstract][Full Text] [Related]
27. LPS signaling enhances hepatic fibrogenesis caused by experimental cholestasis in mice.
Isayama F; Hines IN; Kremer M; Milton RJ; Byrd CL; Perry AW; McKim SE; Parsons C; Rippe RA; Wheeler MD
Am J Physiol Gastrointest Liver Physiol; 2006 Jun; 290(6):G1318-28. PubMed ID: 16439470
[TBL] [Abstract][Full Text] [Related]
28. Systemic ASBT inactivation protects against liver damage in obstructive cholestasis in mice.
Kunst RF; de Waart DR; Wolters F; Duijst S; Vogels EW; Bolt I; Verheij J; Beuers U; Oude Elferink RPJ; van de Graaf SFJ
JHEP Rep; 2022 Nov; 4(11):100573. PubMed ID: 36160754
[TBL] [Abstract][Full Text] [Related]
29. Sirtuin 1 activation alleviates cholestatic liver injury in a cholic acid-fed mouse model of cholestasis.
Kulkarni SR; Soroka CJ; Hagey LR; Boyer JL
Hepatology; 2016 Dec; 64(6):2151-2164. PubMed ID: 27639250
[TBL] [Abstract][Full Text] [Related]
30. Alterations in lipid metabolism mediate inflammation, fibrosis, and proliferation in a mouse model of chronic cholestatic liver injury.
Moustafa T; Fickert P; Magnes C; Guelly C; Thueringer A; Frank S; Kratky D; Sattler W; Reicher H; Sinner F; Gumhold J; Silbert D; Fauler G; Höfler G; Lass A; Zechner R; Trauner M
Gastroenterology; 2012 Jan; 142(1):140-151.e12. PubMed ID: 22001865
[TBL] [Abstract][Full Text] [Related]
31. Protective effect of gastrodin on bile duct ligation-induced hepatic fibrosis in rats.
Zhao S; Li N; Zhen Y; Ge M; Li Y; Yu B; He H; Shao RG
Food Chem Toxicol; 2015 Dec; 86():202-7. PubMed ID: 26498411
[TBL] [Abstract][Full Text] [Related]
32. Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles.
Fickert P; Zollner G; Fuchsbichler A; Stumptner C; Weiglein AH; Lammert F; Marschall HU; Tsybrovskyy O; Zatloukal K; Denk H; Trauner M
Gastroenterology; 2002 Oct; 123(4):1238-51. PubMed ID: 12360485
[TBL] [Abstract][Full Text] [Related]
33. Limb expression 1-like (LIX1L) protein promotes cholestatic liver injury by regulating bile acid metabolism.
Li J; Zhu X; Zhang M; Zhang Y; Ye S; Leng Y; Yang T; Kong L; Zhang H
J Hepatol; 2021 Aug; 75(2):400-413. PubMed ID: 33746084
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic Effect of
Bae UJ; Park BH; Cho MK; Bae EJ
J Med Food; 2022 Jun; 25(6):652-659. PubMed ID: 35708629
[TBL] [Abstract][Full Text] [Related]
35. Modulation of the Tryptophan Hydroxylase 1/Monoamine Oxidase-A/5-Hydroxytryptamine/5-Hydroxytryptamine Receptor 2A/2B/2C Axis Regulates Biliary Proliferation and Liver Fibrosis During Cholestasis.
Kyritsi K; Chen L; O'Brien A; Francis H; Hein TW; Venter J; Wu N; Ceci L; Zhou T; Zawieja D; Gashev AA; Meng F; Invernizzi P; Fabris L; Wu C; Skill NJ; Saxena R; Liangpunsakul S; Alpini G; Glaser SS
Hepatology; 2020 Mar; 71(3):990-1008. PubMed ID: 31344280
[TBL] [Abstract][Full Text] [Related]
36. Plasma biomarkers of liver injury and inflammation demonstrate a lack of apoptosis during obstructive cholestasis in mice.
Woolbright BL; Antoine DJ; Jenkins RE; Bajt ML; Park BK; Jaeschke H
Toxicol Appl Pharmacol; 2013 Dec; 273(3):524-31. PubMed ID: 24096036
[TBL] [Abstract][Full Text] [Related]
37. Dual farnesoid X receptor/TGR5 agonist INT-767 reduces liver injury in the Mdr2-/- (Abcb4-/-) mouse cholangiopathy model by promoting biliary HCO⁻₃ output.
Baghdasaryan A; Claudel T; Gumhold J; Silbert D; Adorini L; Roda A; Vecchiotti S; Gonzalez FJ; Schoonjans K; Strazzabosco M; Fickert P; Trauner M
Hepatology; 2011 Oct; 54(4):1303-12. PubMed ID: 22006858
[TBL] [Abstract][Full Text] [Related]
38. Dithiothreitol supplementation mitigates hepatic and renal injury in bile duct ligated mice: Potential application in the treatment of cholestasis-associated complications.
Heidari R; Ghanbarinejad V; Mohammadi H; Ahmadi A; Esfandiari A; Azarpira N; Niknahad H
Biomed Pharmacother; 2018 Mar; 99():1022-1032. PubMed ID: 29307496
[TBL] [Abstract][Full Text] [Related]
39. Effects of sphingosylphosphorylcholine against cholestatic oxidative stress and liver damage in the common bile duct ligated rats.
Aksu B; Umit H; Kanter M; Guzel A; Inan M; Civelek S; Aktas C; Uzun H
J Pediatr Surg; 2009 Apr; 44(4):702-10. PubMed ID: 19361629
[TBL] [Abstract][Full Text] [Related]
40. Activation of necroptosis in human and experimental cholestasis.
Afonso MB; Rodrigues PM; Simão AL; Ofengeim D; Carvalho T; Amaral JD; Gaspar MM; Cortez-Pinto H; Castro RE; Yuan J; Rodrigues CM
Cell Death Dis; 2016 Sep; 7(9):e2390. PubMed ID: 27685634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
